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ABSTRACT
People undergoing investigations for suspected cancer have to 
undergo a number of investigations before they know their full 
diagnosis and treatment plan. We examined predictors of distress 
among patients undergoing staging investigations for suspected 
colorectal or lung cancer. Patients were prospectively recruited to 
two multi-centre trials comparing WB-MRI with standard scans. 
Patients completed a questionnaire, administered at trial recruit-
ment, measuring demographic and psychological variables 
(n = 129, 66 colorectal, 63 lung; median age 66.4, range: 31–89). 
Predictors of distress were analysed using logistic regression. Forty 
percent of patients reported high distress (a score of 4 or higher on 
the GHQ-12). Higher deprivation and greater intolerance of uncer-
tainty (IU) predicted high distress in both unadjusted (low depriva-
tion: OR 0.352, 95% CIs 0.144 to 0.860, p = 0.022; IU: OR 1.972, 95% 
CIs: 1.357 to 2.865, p < 0.001) and adjusted analyses (low depriva-
tion: OR 0.243, 95% CIs 0.083 to 0.714, p = 0.010; IU: OR 2.231, 95% 
CIs 1.429 to 3.485, p < 0.001). Age, gender, presence of comorbid 
illness, cancer type, probable knowledge of cancer diagnosis, and a 
final diagnosis of cancer did not predict high distress. Future 
research should examine how to reduce distress in patients under-
going investigations for cancer, particularly among those who find 
uncertainty difficult to manage.
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Introduction
Considerable research has examined the psychological impact of having a confirmed 
diagnosis of cancer (Abbey et al., 2015; Dunn et al., 2013; Mitchell et al., 2013), but 
relatively little has looked at distress during the diagnostic phase. People undergoing 
investigations for suspected cancer face the threat of serious illness while having to 
undergo a number of investigations before they know their full diagnosis and treatment 
plan. Cancer diagnostic and staging scans often require injections, some involving 
radioactive ligand (e.g. PET-CT) which may promote fears about radiation risk; while 
others, such as MRI, are noisy and require full body immersion into a relatively narrow 
tube, causing anxiety and claustrophobia in a substantial proportion of patients (Katz et 
al., 1994; Melendez & McCrank, 1993). While a high level of distress is of concern in its 
own right, it is also a predictor of patients’ perceived ‘burden’ whilst undergoing 
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investigative tests such as WB-MRI (Evans et al., 2018), exacerbating the challenges 
patients face during the diagnostic phase.
In their review, Brocken et al. (2012) reported that between 33% and 60% of patients 
undergoing investigations for cancer reported anxiety prior to diagnosis at levels which 
reach the clinical threshold. However, the majority of studies included patients with 
suspected breast cancer. Lung and colorectal cancer are the first and third most common 
cancers worldwide (Bray et al., 2018) yet Brocken et al.’s review included only one study 
on anxiety in patients with suspected lung malignancy and none on patients with 
suspected colorectal cancer (Brocken et al., 2012). Indeed there is evidence that distress 
may vary by cancer site, as higher rates of distress have been reported among people with 
lung cancer than other cancer sites (Zabora et al., 2001) and it is possible that similar 
disparities may be observed in the diagnostic phase.
Research into predictors of distress in the diagnostic phase is also scant, although studies 
on anxiety or depression post-diagnosis suggest certain sectors of the population may be 
more vulnerable; for example, people with a family or personal history of psychiatric 
disorder, people with low socio-economic status, women, and those of a younger age 
(Cardoso et al., 2016; Moseholm et al., 2016; Strong et al., 2007; Walker et al., 2014). 
Intolerance of uncertainty (IU), defined by Dugas et al. (2001) as ‘the excessive tendency of 
an individual to consider it unacceptable that a negative event may occur, however small 
the probability of its occurrence’ is associated with higher levels of negative affect such as 
fear and worry in the short term, and is also a risk factor for the development of 
pathological anxiety (Einstein, 2014). A review of its role in health and health-care related 
outcomes, found poorer tolerance to uncertainty was consistently associated with higher 
distress and a greater tendency to use avoidant coping behaviours (Strout et al., 2018). IU 
has been conceptualised as the ‘filter’ through which events are perceived, while worry 
relates to ‘mental acts’ reflecting a person’s thoughts about a situation and its potential 
outcomes, with worry seen as a product of IU (Buhr & Dugas, 2002). People high on IU 
have been described as lacking the cognitive flexibility needed to cope with a potentially 
life-threatening illness, which among other things, challenges people’s fundamental 
assumptions about themselves and the world (Eisenberg et al., 2015).
Among people diagnosed with cancer, intolerance of uncertainty has been associated 
with higher anxiety among men with low-risk prostate cancer, undergoing active sur-
veillance of their condition (Tan et al., 2016), greater cancer-related distress among 
prostate cancer survivors (Eisenberg et al., 2015), as well as higher depression and poorer 
emotional wellbeing among lung cancer patients (Kurita et al., 2013). Among people at 
higher risk for cancer, low tolerance for ambiguity (one source of uncertainty, Hillen et 
al., 2017) has been associated with high post-counselling distress among people under-
going genetic counselling for hereditary colorectal cancer risk (Codori et al., 2005) and 
higher cancer-related and general distress in women receiving uninformative BRCA1/2 
test results (O’Neill et al., 2006). Collectively this previous research suggests that the 
diagnostic phase may be particularly challenging for people who find uncertainty difficult 
to manage.
The aims of this study were to examine: i) rates of distress among patients undergoing 
staging investigations for suspected colorectal or lung cancer, and ii) predictors of 
distress. We hypothesized distress would be higher among younger people, women, 
those with higher deprivation, lung cancer, and higher intolerance of uncertainty.
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Materials and methods
Patients were recruited to two parallel multi-centre clinical trials, comparing the 
diagnostic accuracy and cost-effectiveness of WB-MRI with standard tests for staging 
colorectal (Streamline C) and lung cancer (Streamline L). The trials received ethical 
approval from the Camden and Islington National Research Ethics Service (NRES) on 
03/10/2012, project numbers: 12/LO/1176 (Streamline C) and 12/LO/1177 (Streamline 
L). Eligible patients had known or suspected colorectal or lung cancer and were due to 
undergo staging. The full protocols can be found at (Taylor et al., 2017) and the main 
outcomes have been reported (Taylor, Mallett, Ball et al., 2019; Taylor, Mallett, Beare et 
al., 2019). As part of the main trials, patients underwent WB-MRI in addition to all 
standard staging tests, and were also invited to complete postal questionnaires before 
and after staging.
Participants were recruited to the Streamline trials from 22 hospitals in the UK, and 
consented to participate in either an interview or one of the two questionnaire studies, to 
gauge their experience of staging and the influence of scan attributes on scan preference. 
The results of the interview study (Evans et al., 2017) and a discrete choice experiment 
assessing the influence of scan attributes on patient preferences (Miles et al., 2019) have 
been reported elsewhere, as has data from the present cohort on the perceived burden of 
WB-MRI vs. standard staging scans (Evans et al., 2018). This current report describes 
predictors of distress assessed in the baseline questionnaire.
Questionnaires
Patients were mailed the baseline questionnaire by the UCL Cancer Trials Centre within 
1 to 2 days after consenting to participate, and while they were still undergoing staging 
investigations. Patients were also invited to complete a post-staging questionnaire (not 
reported here) in order to assess patient experience of and preferences for the different 
staging scans. The study was originally powered to assess the comparative patient 
perceived burden of WB-MRI and standard staging tests (Evans et al., 2018).
Emotional distress
The 12 item General Health Questionnaire (GHQ-12) was used to assess probable 
emotional distress. An example item is, ‘In the last three months have you . . ..been able 
to face up to your problems?’ Using the GHQ-12 binary coding method (0,0,1,1), a mean 
sum score (if at least 50% of items were answered) was created ranging from 0 to 12 
(Goldberg et al., 1997). A score of 4 or more is considered indicative of high distress levels 
(Knott, 2013).
Demographics
Patients were asked their age and gender. Missing demographic data on age and gender 
as well as zip code data were supplied via the central trial database (with patient consent). 
Zip code data were used to calculate an area-based deprivation score for each individual 
using the 2010 IMD scale (McLennan et al., 2011), categorised into quintiles from 1 
(highest levels of deprivation) to 5 (lowest).
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Co-morbidity
Patients were asked about their current and recent physical health and mental well-being. 
Patients were asked to report (‘yes’ or ‘no’) whether they had any of the following 
diseases: heart or vascular disease, diabetes, epilepsy, stroke, arthritis, asthma, mental 
or emotional disorder. There was also an option to provide details of other illnesses. A 
response of ‘yes’ to any illness was coded and summed to form a dichotomous ‘co- 
morbidity’ variable (‘present’ or ‘absent’), excluding mental or emotional disorder as this 
was captured in the GHQ-12.
Aware of diagnosis at the time of completing the baseline questionnaire
Knowledge of confirmed cancer diagnosis was not asked directly, but was estimated 
based on date of primary biopsy and date of registration to the trials, which were both 
recorded by the central trial database. Patients whose date of primary biopsy was 
equivalent to or earlier than their date of registration to the trial were categorised as 
probably knowing their cancer diagnosis at the time of completing the baseline ques-
tionnaire. Those whose date of primary biopsy was later were categorised as probably not 
knowing their cancer diagnosis at the time of questionnaire completion. The majority of 
patients had a date of primary biopsy (n = 100, 77.5%). In cases where there was no 
primary biopsy, other dates were used in the following order of priority: date of biopsy of 
spread (e.g. lymph nodes) (n = 6, 4.7%), date of surgical resection (n = 10, 7.8%), date of 
withdrawal from the trial due to a non-cancer diagnosis (n = 9, 7.0%), and date of MDT 
(n = 3, 2.3%). One person had no date recorded of their recruitment to the trial and were 
later then deemed ineligible (as the cancer was a recurrence, not a primary).
Final diagnosis
This was recorded by the central trial database (cancer, not cancer). One person did not 
have the WB-MRI scan so their diagnosis was unknown.
Intolerance of uncertainty
This was measured using the four highest loadings items on the subscale ‘Uncertainty is 
stressful and upsetting’ of the Intolerance of uncertainty measure (Buhr & Dugas, 2002) 
(loadings 0.53–0.74). (‘My mind can’t be relaxed if I don’t know what will happen 
tomorrow’, ‘Uncertainty makes life intolerable’, ‘Uncertainty makes me uneasy, anxious 
or stressed’, ‘Uncertainty keeps me from sleeping soundly’). Participants were given the 
following instructions: ‘You will find below a series of statements which describe how 
people may react to the uncertainties of life. Please use the scale below to describe to what 
extent each item is characteristic of you. Please circle a number (1 to 5) that describes you 
best.’ Response options 1–5 with 1 anchored ‘not at all characteristic of me,’ and 5 
anchored ‘entirely characteristic of me’ with the mid-point (3) labelled ‘somewhat 
characteristic of me’. Internal reliability of the scale was good (Cronbach’s alpha = 0.903). 
(Only one person answered fewer than half – 2 – of the items).
Statistical analysis
Data were analysed using SPSS version 24. Demographics of responders and non- 
responders, and of participants recruited to Streamline C and Streamline L, were 
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analysed using independent t-tests or Mann-Whitney U for continuous variables, and 
chi-square or Fisher’s exact for categorical variables.
Logistic regression was used to identify predictors of high levels of emotional distress 
(yes, no). Predictors (age, gender, deprivation, cancer type, presence of comorbidities, 
awareness of diagnosis, final diagnosis, and intolerance to uncertainty) were entered 
individually in an unadjusted analysis, and altogether in an adjusted analysis.
Age and deprivation levels were collapsed into three groups. For age, this was to check 
for non-linear associations with distress (categories were: 30–49, 50–69, 70–89). For 
deprivation, it was to increase the sample size in each category (categories were: groups 1 
and 2 – highest deprivation, group 3, and groups 4 and 5 – lowest deprivation.
Results
Response rates
During the study period (March 2013 and July 2015) 392 people were recruited to the 
Streamline trials of whom 350 (89.3%) agreed to participate in the questionnaire or 
interview study (see Figure 1). Ninety-one were recruited for the interview study and 
three were not sent the baseline questionnaire. Of those sent the baseline questionnaire 
(n = 256), 117 did not complete it, and 10 returned it but had not completed the GHQ-12 
(total non-response = 127), leaving 129 in the final study cohort.
There were no significant differences between participants and non-responders in terms 
of median age (z = 0.184; p = 0.854), cancer type [colorectal or lung] (chi-square = 0.015; 
df = 1; p = 0.902), gender (chi-square = 2.544, df = 1, p = 0.111) or deprivation (chi- 
square = 4.543; df = 2; p = 0.103).
Participant characteristics
Median participant age was 66.4 (range: 31–89), with no differences between men and 
women (66.6 vs 64.9 respectively; z = 0.730, p = 0.466). Seventy-seven (59.7%) were male, 
and seventy four (57.4%) reported at least one additional comorbidity (see Table 1). The 
majority (89.1%, n = 115) were ultimately diagnosed with cancer.
Patients recruited to Streamline C were younger, less likely to report comorbidities, 
more likely to be diagnosed with cancer at the end of staging, and more likely to be 
potentially aware of their diagnosis at the time of completing the baseline questionnaire 
than patients recruited to Streamline L. There were no differences between Streamline C 
and Streamline L cohorts regarding gender, deprivation, intolerance to uncertainty and 
presence of high emotional distress (see Table 1).
Predictors of distress
In unadjusted analyses, high distress was predicted by higher deprivation and greater 
intolerance of uncertainty. While cancer type alone did not significantly predict high 
distress (Table 2), Streamline C patients were more likely to (probably) know their 
diagnosis at the time of completing the questionnaire (Table 1). Adjusting for probable 
knowledge of diagnosis showed Streamline C patients had lower levels of distress than 
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Streamline L (OR: 0.410, CIs: 0.179 to 0.938, p = 0.035). There was also a non-significant 
trend towards a greater likelihood of high distress among patients aware of their 
diagnosis (OR: 2.055, CIs: 0.890 to 4.749, p = 0.092). However when all the variables 
were entered into the analysis together, only higher deprivation and greater intolerance 
of uncertainty were predictive of high distress, although awareness of diagnosis 
approached significance. The analysis was repeated separately for people who probably 
knew vs probably did not know their diagnosis (cancer vs. not cancer) at the time of 
completing the GHQ-12 and the pattern of significant results was broadly similar (see 
Supplementary data). In addition, the interaction between intolerance to uncertainty and 
probably knowledge of diagnosis was not significant (OR: 0.727, 95% CIs: 0.328 to 1.608, 
p = 0.431).
Figure 1. Flow Chart showing flow of participants in study.
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Discussion
Research to date shows a substantial proportion of people undergoing investigations for 
cancer have high levels of distress, with rates similar to people with a confirmed diagnosis 
of cancer (Brocken et al., 2012). This study examined distress among patients undergoing 
staging investigations for suspected colorectal or lung cancers. In line with predictions, 
higher rates of distress were associated with higher deprivation and high intolerance to 
uncertainty both in unadjusted and adjusted analyses. Rates of distress observed in our 
study among people with suspected colorectal (33.3%) and lung cancer (46.0%) were 
comparable to rates observed in people with confirmed diagnoses (colon: 31.6% and 
lung: 43.4% (Zabora et al., 2001)), and to rates of anxiety observed in the diagnostic phase 
of between 33% and 60% in other cancer groups (Brocken et al., 2012). Although one 
study found 40% of patients with colorectal cancer reported high levels of anxiety, it was 
assessed retrospectively and did not use a validated measure (Wiljer et al., 2013). Distress 
rates only significantly differed by cancer type once probable knowledge of diagnosis was 
entered into the model (as people with suspected colorectal cancer were more likely to 
Table 1. Participant characteristics. Numbers are percent (n) unless otherwise specified.
Overall 
(N = 129)
Colorectal 
(N = 66)
Lung 
(N = 63) Significance
Agea Median: 
66.4
64.2 69.2 z = 2.313, p = 0.021
30–49 7.0 (9) 12.1 (8) 1.6 (1)
50–69 51.2 (66) 53.0 (35) 49.2 
(31)
70–89 41.9 (54) 34.8 (23) 49.2 
(31)
Gender 
(% male) a
59.7 (77) 59.1 (39) 60.3 
(38)
Chi-square = 0.020; df = 1; 
p = 0.887
Deprivation a Chi-square = 2.442; df = 2; 
p = 0.295
1 & 2 48.8 (63) 43.9 (29) 54.0 
(34)
3 20.9 (27) 19.7 (13) 22.2 
(14)
4 & 5 30.2 (39) 36.4 (24) 23.8 
(15)
Comorbiditya 57.4 (74) 47.0 (31) 68.3 
(43)
Chi-square = 5.970; df = 1; 
p = 0.015
Ultimately diagnosed with cancer b Fisher’s exact, p < 0.001
Yes 89.1 (115) 65 (98.5) 50 
(79.4)
No 10.1 (13) 1 (1.5) 12 
(19.0)
Unknown 0.8 (1) 0 (0) 1 (1.6)
Potentially aware of cancer diagnosis at time of GHQ- 
12 completionb
Chi-square = 24.470, df = 1, 
p < 0.001
Probably not 43.8 (56) 22.7 (15) 66.1 
(44)
Possibly yes 56.3 (72) 77.3 (51) 33.9 
(21)
Intolerance of uncertaintyb 
(mean, sd)
2.31 
(1.06)
2.32 
(1.00)
2.31 
(1.14)
t = −0.084; df = 122; 
p = 0.933
High emotional distress (GHQ-12 score of 4 or more) a 39.5 (51) 33.3 (22) 46.0 
(29)
Chi-square = 2.174, df = 1, 
p = 0.140
ano missing data 
bmissing data less than 5%
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know this). However, once other variables were added into the model, cancer type did 
not significantly predict distress. Contrary to predictions, we found no association 
between distress and either age or gender. Only a small number of people were aged 
under 49, meaning there was reduced statistical power needed to detect age effects in the 
youngest group, but no differences were observed between those aged 50–69 and 70–89 
either. The lack of association between gender and distress is more surprising, although a 
recent systematic review of predictors of distress one or more years after a cancer 
diagnosis found little evidence gender or age were predictors (Cook et al., 2018).
Study limitations
The study has a number of limitations. The design was cross-sectional, and the direction 
of influence of variables is unknown – hence while intolerance of uncertainty may predict 
high distress, high distress may equally reduce people’s ability to tolerate uncertainty. In 
addition, the questions used to assess uncertainty intolerance came from a subset of a 
questionnaire, and assessed people’s views about the negative consequences of uncer-
tainty, and did not ask about positive responses to uncertainty (Hillen et al., 2017). As 
such, the association between high distress and intolerance of uncertainty could partially 
Table 2. Predictors of high distress at baseline.
Proportion with high 
distress (n) Unadjusted (n = 129)
Adjusted (all variables entered into the ana-
lysis together) (N = 121)
Demographics
Agea -
30–49 55.6 (5) 2.303 (0.552 to 9.608) 3.475 (0.598 to 20.181)
50–69 40.9 (27) 1.275 (0.606 to 2.682) 1.079 (0.443 to 2.629)
[70–89] 35.2 (19) [1.00] [1.00]
Gendera
Female 36.5 (19) [1.00] [1.00]
Male 41.6 (32) 1.235 (0.599 to 2.547) 1.341 (0.533 to 3.249)
Deprivationa
[1 and 2] 46.0 (29) [1.00] [1.00]
3 48.1 (13) 1.089 (0.441 to 2.686) 1.019 (0.360 to 2.883)
4 and 5 (lower 
deprivation)
23.1 (9) 0.352 (0.144 to 0.860) 
p = 0.022
0.243 (0.083 to 0.714) 
p = 0.010
Clinical and 
psychological 
variables
Comorbiditya
No 36.4 (20) [1.00] [1.00]
Yes 41.9 (31) 1.262 (0.616 to 2.586) 0.927 (0.375 to 2.291)
Cancer site a
Lung 46.0 (29) [1.00] [1.00]
Colorectal 33.3 (22) 0.586 (0.288 to 1.195) 0.459 (0.169 to 1.243)
Aware of diagnosis b
Probably not 35.7 (20) [1.00] [1.00]
Probably yes 43.1 (31) 1.361 (0.663 to 2.792) 2.358 (0.885 to 6.286) 
p = 0.086
Ultimately diagnosed 
with cancer b
No 38.5 (5) [1.00] [1.00]
Yes 39.5 (45) 1.043 (0.321 to 3.392) 0.526 (0.118 to 2.339)
Intolerance of 
uncertainty b
- 1.972 (1.357 to 2.865) 
p < 0.001
2.231 (1.429 to 3.485) 
p < 0.001
ano missing data 
bless than 5% missing data
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reflect a negative response bias. There is also some conceptual overlap between the items 
on the GHQ-12 distress scale and the intolerance to uncertainty scale – such as the 
question assessing uncertainty as causing anxiety and stress, which may have inflated 
associations between distress and IU. A recent review of the concept of IU called for the 
development of broader measures, including both positive and negative responses to 
uncertainty (Hillen et al., 2017), and such measures may show different relationships 
with distress.
A further limitation is that patients were not asked directly whether they knew their 
cancer diagnosis at time of baseline questionnaire completion. Instead, an indicator of 
probable knowledge was used, based primarily on date of primary biopsy. Equally, 
although patients were sent the baseline questionnaire on recruitment to the trial, we 
do not know how many completed it after their staging investigations had been 
completed.
This study demonstrates that a substantial proportion of patients undergoing staging 
investigations for suspected lung or colorectal cancer experience significant levels of 
distress. A Canadian study reporting on patients with a confirmed diagnosis of colorectal 
cancer attending clinics for follow-up care, found patients retrospectively reported 
feeling high anxiety levels during the diagnostic phase, with 31.6% reporting informa-
tional and 20.3% reporting emotional needs during this time (Wiljer et al., 2013). While 
the majority (84%) said their needs had been met, a high proportion of patients (77.9%) 
stated they had not been directed to any sources of help in coping with their anxiety. 
Together with the current study, such research points to the need for more patient 
support while undergoing investigations for cancer.
In conclusion, a substantial proportion of patients experience high distress while 
undergoing staging investigations for a suspected or confirmed cancer diagnosis. 
Future research should assess distress associated with both waiting for a cancer diagnosis 
and also waiting for a prognosis (once the diagnosis has been made), and examine how 
best to reduce distress, particularly among those at higher risk such as people with higher 
levels of deprivation and uncertainty intolerance.
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